BMP7 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-BMP7 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | BMP7 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mg |
| Concentration | 1mg/ml |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Western blot analysis of Prostate cell and Kidney cell lysate using BMP7 antibody. Bone morphogenetic proteins (BMPs) were first identified as molecules that can induce ectopic bone and cartilage formation (1, 2). BMPs belongs to the TGF-2 superfamily, playing many diverse functions during development (3). BMPs are synthesized as precursor proteins and then processed by cleavage to release the c-terminal mature BMP. BMPs initiate signaling by binding to a receptor complex containing type I and type II serine/threonine receptor kinases that then phosphorylate Smad (mainly Smad1,5 and 8), resulting the translocation of Smad into the nucleus. BMP was also reported to activate MAPK pathways in some systems (3, 4). BMP7, also known |
| Immunogen | Immunogen: Recombinant protein of human BMP7 |
| Other Names | [bone morphogenetic protein 7 preproprotein; Bone morphogenetic protein 7; bone morphogenetic protein 7; bone morphogenetic protein 7; Osteogenic protein 1; OP-1; INN: Eptotermin alfa], [BMP7; BMP7; OP-1; OP1; BMP-7; OP-1] |
| Gene, Accession # | [BMP7], Gene ID: 655, NCBI: NP_001710.1, UniProt: P18075 |
| Catalog # | MBS419463 |
| Price | $385 |
| Order / More Info | BMP7 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies